GB8417207D0 - Antitumor formulation - Google Patents

Antitumor formulation

Info

Publication number
GB8417207D0
GB8417207D0 GB848417207A GB8417207A GB8417207D0 GB 8417207 D0 GB8417207 D0 GB 8417207D0 GB 848417207 A GB848417207 A GB 848417207A GB 8417207 A GB8417207 A GB 8417207A GB 8417207 D0 GB8417207 D0 GB 8417207D0
Authority
GB
United Kingdom
Prior art keywords
antitumor formulation
antitumor
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB848417207A
Other versions
GB2143732A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of GB8417207D0 publication Critical patent/GB8417207D0/en
Publication of GB2143732A publication Critical patent/GB2143732A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB08417207A 1983-07-06 1984-07-05 Homocarnosine for antitumor formulation Withdrawn GB2143732A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58122986A JPS6016926A (en) 1983-07-06 1983-07-06 Antineoplastic agent

Publications (2)

Publication Number Publication Date
GB8417207D0 true GB8417207D0 (en) 1984-08-08
GB2143732A GB2143732A (en) 1985-02-20

Family

ID=14849460

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08417207A Withdrawn GB2143732A (en) 1983-07-06 1984-07-05 Homocarnosine for antitumor formulation

Country Status (3)

Country Link
JP (1) JPS6016926A (en)
DE (1) DE3424997A1 (en)
GB (1) GB2143732A (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU638681B2 (en) * 1988-09-28 1993-07-08 Commonwealth Scientific And Industrial Research Organisation Compound and method for the retardation of collagen cross-linking
WO1990006102A1 (en) * 1988-09-28 1990-06-14 Peptide Technology Limited Compound and method for the retardation of collagen cross-linking
AUPM463794A0 (en) * 1994-03-22 1994-04-14 Commonwealth Scientific And Industrial Research Organisation Inhibition of growth of cancer cells by carnosine
RU2217196C2 (en) * 2002-02-28 2003-11-27 Небольсин Владимир Евгеньевич Method for induction of cells differentiation
JP4989841B2 (en) * 2003-10-16 2012-08-01 株式会社優芳舞 Angiogenesis inhibitors, therapeutic or preventive agents for diseases associated with angiogenesis
JP2012219080A (en) * 2011-04-12 2012-11-12 Anbas:Kk Composition for suppressing formation or proliferation of tumor by oral administration

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3497355A (en) * 1968-01-11 1970-02-24 Gaf Corp Diazotype reproduction material comprising a diazonium compound and method of use

Also Published As

Publication number Publication date
DE3424997A1 (en) 1985-01-31
DE3424997C2 (en) 1987-10-15
GB2143732A (en) 1985-02-20
JPS6016926A (en) 1985-01-28
JPH0378368B2 (en) 1991-12-13

Similar Documents

Publication Publication Date Title
CS350984A2 (en) Zpusob vyroby n fosfonomethylglycinu
EP0135820A3 (en) Antitumor agent
GB8416634D0 (en) Antineoplastic agent
GB8417207D0 (en) Antitumor formulation
DE3473913D1 (en) Fitting
GB8301754D0 (en) Formulation
GB2143146B (en) Colour formulation
CS325284A2 (en) Zpusob vyroby n oxidu esteru pyridylkarboxylovych kyselin
GB8428144D0 (en) Hydrophilic-film-forming preparation
GR80789B (en) Iodacetamide
ZA846624B (en) Antitumor agent
DE3365127D1 (en) Antitumor agent
ZA845372B (en) Antitumor agent
JPS57179163A (en) Antitumor
GB8308313D0 (en) Formulation
IL69414A0 (en) Cosmetic-pharmaceutical formulation
GB8326646D0 (en) Formulation
CS252383A1 (en) Zpusob uvolnovani sypkych latek skladovanych v zasobnicich
CA50759S (en) Fitting
CS548783A1 (en) Univerzalni prives osobniho automobilu
CS864183A1 (en) Sposob ziskavania koncentratov n hexanu izomerizaciou
CS729883A1 (en) Sposob vyroby n alkanmonokarboxylovych kyselin
CS453883A1 (en) Zpusob pripravy n allylovanych derivatu aromatickych aminu
PL240667A2 (en) Washing-disinfecting preparation
GB8329367D0 (en) Umbrella-holding extension

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)